RONALD HUNT

Insider Reports History

Location
New York, NY
Signature
By: /s/ Michael Greco, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RONALD HUNT:

Company Role Class Num Shares Value Price $ Report Date Ownership
Iterum Therapeutics plc Director Ordinary Shares 253,898 $355,457 $1.40 06 Aug 2024 By New Leaf Ventures III, L.P.
Iterum Therapeutics plc Director Ordinary Shares 91,122 $127,571 $1.40 06 Aug 2024 By New Leaf Biopharma Opportunities II, L.P.
Rallybio Corp Director Option (Right to Buy) 28,500 $51,500 $0.7000 13 May 2025 Direct
Rallybio Corp Director Option (Right to Buy) 16,500 $29,205 $1.77 15 May 2024 Direct
Iterum Therapeutics plc Director Warrants (right to buy) 182,453 06 Aug 2024 By New Leaf Ventures III, L.P.
Iterum Therapeutics plc Director Warrants (right to buy) 65,481 06 Aug 2024 By New Leaf Biopharma Opportunities II, L.P.
Harpoon Therapeutics, Inc. Director, 10%+ Owner 8.000% Series A Redeemable Preferred Stock 0 11 Mar 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 11 Mar 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 11 Mar 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 0 11 Mar 2024 Direct
Iterum Therapeutics plc Director Subscription Rights (right to buy) 0 06 Aug 2024 By New Leaf Biopharma Opportunities II, L.P.
Iterum Therapeutics plc Director Subscription Rights (right to buy) 0 06 Aug 2024 By New Leaf Ventures III, L.P.
Iterum Therapeutics plc Director 6.500% Exchangeable Senior Subordinated Note due 2025 $0 13 Jan 2025 By New Leaf Biopharma Opportunities II, L.P.
Iterum Therapeutics plc Director 6.500% Exchangeable Senior Subordinated Note due 2025 $0 13 Jan 2025 By New Leaf Ventures III, L.P.

Insider Reports Filed by RONALD HUNT

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RLYB Rallybio Corp 13 May 2025 1 $0 4 Director 15 May 2025, 17:08
ITRM Iterum Therapeutics plc 13 Jan 2025 2 -$3,000,000 4 Director 23 Jan 2025, 18:30
RLYB Rallybio Corp 02 Jan 2025 1 +$51,500 4 Director 06 Jan 2025, 17:07
ITRM Iterum Therapeutics plc 06 Aug 2024 8 $0 4 Director 12 Aug 2024, 09:00
RLYB Rallybio Corp 15 May 2024 1 $0 4 Director 17 May 2024, 17:06
/report/000095017024029446-hunt-ronald-2024-03-08 Harpoon Therapeutics, Inc. 08 Mar 2024 12 $0 4 Director, 10%+ Owner 11 Mar 2024, 17:26
RLYB Rallybio Corp 02 Jan 2024 1 +$51,500 4 Director 04 Jan 2024, 17:56
/report/000095017024000960-hunt-ronald-2024-01-01 Harpoon Therapeutics, Inc. 01 Jan 2024 1 $0 4 Director, 10%+ Owner 03 Jan 2024, 16:30
/report/000120919123056796-hunt-ronald-2023-11-27 Harpoon Therapeutics, Inc. 27 Nov 2023 1 $0 4 Director, 10%+ Owner 28 Nov 2023, 16:25
/report/000120919123053737-hunt-ronald-2023-10-25 Harpoon Therapeutics, Inc. 25 Oct 2023 4 $0 4 Director, 10%+ Owner 27 Oct 2023, 16:03
/report/000120919123051149-hunt-ronald-2023-10-01 Harpoon Therapeutics, Inc. 01 Oct 2023 1 $0 4 Director, 10%+ Owner 02 Oct 2023, 17:35
ITRM Iterum Therapeutics plc 01 Oct 2023 2 $0 4 Director 02 Oct 2023, 09:22
/report/000120919123041671-hunt-ronald-2023-07-01 Harpoon Therapeutics, Inc. 01 Jul 2023 1 $0 4 Director, 10%+ Owner 06 Jul 2023, 18:36
ITRM Iterum Therapeutics plc 01 Jul 2023 2 $0 4 Director 03 Jul 2023, 08:00
/report/000120919123039413-hunt-ronald-2023-06-22 Harpoon Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director, 10%+ Owner 23 Jun 2023, 16:34
RLYB Rallybio Corp 17 May 2023 1 $0 4 Director 19 May 2023, 17:22
/report/000120919123022802-hunt-ronald-2023-04-01 Harpoon Therapeutics, Inc. 01 Apr 2023 1 $0 4 Director, 10%+ Owner 04 Apr 2023, 17:05
ITRM Iterum Therapeutics plc 01 Apr 2023 2 $0 4 Director 03 Apr 2023, 20:00
/report/000089924323009741-hunt-ronald-2023-03-23 Harpoon Therapeutics, Inc. 23 Mar 2023 2 +$10,000,000 4 Director, 10%+ Owner 27 Mar 2023, 17:37
RLYB Rallybio Corp 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:25
ITRM Iterum Therapeutics plc 01 Jan 2023 2 $0 4 Director 04 Jan 2023, 17:00
ITRM Iterum Therapeutics plc 23 Dec 2022 1 $0 4 Director 28 Dec 2022, 20:00
ITRM Iterum Therapeutics plc 25 Sep 2022 1 $0 4 Director 27 Sep 2022, 21:00
ITRM Iterum Therapeutics plc 25 Jun 2022 1 $0 4 Director 28 Jun 2022, 21:00
ITRM Iterum Therapeutics plc 23 Jun 2022 2 $0 4 Director 24 Jun 2022, 18:00
/report/000120919122039326-hunt-ronald-2022-06-22 Harpoon Therapeutics, Inc. 22 Jun 2022 2 +$44,999 4 Director, 10%+ Owner 24 Jun 2022, 18:46
ITRM Iterum Therapeutics plc 15 Jun 2022 1 +$6,471 4 Director 17 Jun 2022, 17:00
RLYB Rallybio Corp 24 May 2022 1 $0 4 Director 26 May 2022, 20:11
ITRM Iterum Therapeutics plc 25 Mar 2022 1 $0 4 Director 29 Mar 2022, 20:00
RLYB Rallybio Corp 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:41
RLYB Rallybio Corp 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 19:35
RLYB Rallybio Corp 28 Jul 2021 7 +$3,999,996 4 Director 04 Aug 2021, 17:51
ITRM Iterum Therapeutics plc 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 16:05
/report/000120919121032954-hunt-ronald-2021-05-04-restatement Harpoon Therapeutics, Inc. 04 May 2021 2 $0 4/A Director, 10%+ Owner 14 May 2021, 20:01
/report/000089924321032747-hunt-ronald-2021-01-11 Harpoon Therapeutics, Inc. 11 Jan 2021 1 +$3,999,998 4 Director, 10%+ Owner 12 Aug 2021, 16:15